Evaluation of Approach to Predict the Contribution of Multiple Cytochrome P450s in Drug Metabolism Using Relative Activity Factor: Effects of the Differences in Expression Levels of NADPH–Cytochrome P450 Reductase and Cytochrome b5 in the Expression System and the Differences in the Marker Activities
- 1 April 2002
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 91 (4) , 952-963
- https://doi.org/10.1002/jps.10091
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 14 references indexed in Scilit:
- Activation of phenacetinO-deethylase activity byα-naphthoflavone in human liver microsomesXenobiotica, 1999
- Use of heterologously expressed human cytochrome P4501A2 to predict tacrine-fluvoxamine drug interaction in manPharmacogenetics, 1998
- Drug metabolism by Escherichia coli expressing human cytochromes P450Nature Biotechnology, 1997
- Prediction of in vivo drug metabolism in the human liver from in vitro metabolism dataPharmacology & Therapeutics, 1997
- P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclaturePharmacogenetics, 1996
- Xenobiotic-metabolizing human cells as tools for pharmacological and toxicological researchPublished by Elsevier ,1995
- Clinical Importance of Hepatic Cytochrome P450 in Drug MetabolismDrug Metabolism Reviews, 1995
- Validation and use of cloned, expressed human drug-metabolizing enzymes in heterologous cells for analysis of drug metabolism and drug-drug interactionsBiochemical Pharmacology, 1993
- [51] Site of action of substrates requiring cytochrome b5 for oxidation by cytochrome P450Published by Elsevier ,1991
- High-performance liquid chromatographic assays for bufuralol 1′-hydroxylase, debrisoquine 4-hydroxylase, and dextromethorphan O-demethylase in microsomes and purified cytochrome P-450 isozymes of human liverAnalytical Biochemistry, 1987